PUURS, Belgium, April 23 (Reuters) - The European Commission will conclude in the next few days a deal with BionTech/Pfizer for the delivery over 2021-2023 of 1.8 billion vaccines against the coronavirus, the head of the EU executive arm Ursula von der Leyen said on Friday.
“We are working with Biontech/Pfizer on a new contract,” von der Leyen told a news conference at the vaccine production site.
“This will foresee 1.8 billion does for 2021-2023. We will conclude in the next days. It will secure the doses necessary to give booster shots to increase immunity,” she said. (Reporting by Francesco Guarascio, writing by Jan Strupczewski)
Our Standards: The Thomson Reuters Trust Principles.